DEXCOM INC. DL-,001/ US2521311074 /
17/05/2024 19:32:06 | Chg. +0.56 | Volume | Bid20:04:55 | Ask20:04:55 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
120.78EUR | +0.47% | 0 Turnover: 0.00 |
120.34Bid Size: 420 | 120.80Ask Size: 420 | 48.13 bill.EUR | - | - |
GlobeNewswire
08/04
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
31/01
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.